Comprehensive Vasodilation vs. Usual Care—Mortality and Rehospitalization for Heart Failure – American College of Cardiology
Ragavendra R. Baliga, MBBS, FACC
Related Articles
HeartCARE Center Recognition Program
ACC Accreditation Services 2400 N. St. NW Washington, DC 20037 Please note address change for ACC Accreditation Services Every day, you demonstrate your commitment to…
ACCEL Lite: ZENITH Phase 3 Trial: Sotatercept in Pulmonary Arterial Hypertension With High Mortality Risk – American College of Cardiology
The ZENITH trial evaluated sotatercept, an activin signaling inhibitor, in patients with advanced pulmonary arterial hypertension (PAH) at high risk of death. Sotatercept met its…
Cardio-Obstetrics Essentials: Team-Based Management of Cardiovascular Disease and Pregnancy – American College of Cardiology
Meeting Type: Live Meetings Location: Virtually and Heart House, Washington, DC Join card io-obstetrics experts, including Course Chair Natalie Bello, MD, MPH, FACC and Course…
Vutrisiran and All-Cause Mortality, Prognostic Implication of sTTR Levels in Patients With ATTR-CM | JACC Special Focus Issue – American College of Cardiology
Studies exploring the association between vutrisiran and all-cause mortality and the prognostic information gleaned from serum transthyretin (sTTR) levels in patients with transthyretin amyloid cardiomyopathy…
Call for Nominations for Vice President and Trustees – American College of Cardiology
Nominations are due by June 23, 2023. Submit your nominations today!
Sports and Exercise Cardiology: Highlights From the 2025 American College of Cardiology Scientific Session and Expo – American College of Cardiology
The discipline of sports cardiology continues to make major advancements marked by emerging evidence to guide the cardiovascular care of athletes, culminating in the recent…
The ACC Celebrates Nurses
To celebrate Nurse Appreciation Month, the ACC is offering 40% off new membership to show our gratitude for your commitment to delivering the highest standards…
Amiloride Noninferior to Spironolactone For Resistant Hypertension – American College of Cardiology
Amiloride is noninferior to spironolactone in lowering home-measured systolic blood pressure (SBP) among patients with resistant hypertension, according to results from a clinical trial published…
Cardiovascular Disease & Stroke Prevention – American College of Cardiology
Review strategies to prevent an acute event through risk stratification, as well as lifestyle and pharmaceutical measures to control dyslipidemia, blood pressure, and diabetes as…
Can Modifiable Lifestyle Factors Lower Cardiac Conduction Disease Risk? | JACC: Asia – American College of Cardiology
Three modifiable risk factors – excessive alcohol consumption, high sedentary behavior and longer nighttime sleep duration – are associated with higher risk of cardiac conduction…